US Patent 8143216 Modified human growth hormone
Patent 8143216 was granted and assigned to Ambrx on March, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8143216 Modified human growth hormone
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
